Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Trojer

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 16, 2007
A novel arginine methyltransferase inhibitor with cellular activityAstrid Spannhoff, Rospita Machmur, Ralf Heinke, et al.
Journal of Medicinal Chemistry|April 17, 2007
Target-based approach to inhibitors of histone arginine methyltransferasesAstrid Spannhoff, Ralf Heinke, Ingo Bauer, et al.
Cancer Research|December 29, 2017
A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2'-DeoxycytidineBenjamin R Leadem, Ioannis Kagiampakis, Catherine Wilson, et al.
Nucleic Acids Research|July 11, 2003
Histone deacetylases in fungi: novel members, new factsPatrick Trojer, Eva M Brandtner, Gerald Brosch, et al.
Journal of Medicinal Chemistry|February 28, 2007
Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluationsRino Ragno, Silvia Simeoni, Sabrina Castellano, et al.
Plos One|April 18, 2014
De novo peptide design and experimental validation of histone methyltransferase inhibitorsJames Smadbeck, Meghan B Peterson, Barry M Zee, et al.
Plos One|March 4, 2014
De novo peptide design and experimental validation of histone methyltransferase inhibitorsJames Smadbeck, Meghan B Peterson, Barry M Zee, et al.
The Journal of Clinical Investigation|January 17, 2013
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programsAlexandros Tzatsos, Polina Paskaleva, Francesco Ferrari, et al.
Molecular & Cellular Proteomics : MCP|February 15, 2015
Mass spectrometric quantification of histone post-translational modifications by a hybrid chemical labeling methodTobias M Maile, Anita Izrael-Tomasevic, Tommy Cheung, et al.
The Journal of Biological Chemistry|October 8, 2009
The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrateYan Li, Patrick Trojer, Chong-Feng Xu, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|June 16, 2007
A novel arginine methyltransferase inhibitor with cellular activityAstrid Spannhoff, Rospita Machmur, Ralf Heinke, et al.
Journal of Medicinal Chemistry|April 17, 2007
Target-based approach to inhibitors of histone arginine methyltransferasesAstrid Spannhoff, Ralf Heinke, Ingo Bauer, et al.
Cancer Research|December 29, 2017
A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2'-DeoxycytidineBenjamin R Leadem, Ioannis Kagiampakis, Catherine Wilson, et al.
Nucleic Acids Research|July 11, 2003
Histone deacetylases in fungi: novel members, new factsPatrick Trojer, Eva M Brandtner, Gerald Brosch, et al.
Journal of Medicinal Chemistry|February 28, 2007
Small molecule inhibitors of histone arginine methyltransferases: homology modeling, molecular docking, binding mode analysis, and biological evaluationsRino Ragno, Silvia Simeoni, Sabrina Castellano, et al.
Plos One|April 18, 2014
De novo peptide design and experimental validation of histone methyltransferase inhibitorsJames Smadbeck, Meghan B Peterson, Barry M Zee, et al.
Plos One|March 4, 2014
De novo peptide design and experimental validation of histone methyltransferase inhibitorsJames Smadbeck, Meghan B Peterson, Barry M Zee, et al.
The Journal of Clinical Investigation|January 17, 2013
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programsAlexandros Tzatsos, Polina Paskaleva, Francesco Ferrari, et al.
Molecular & Cellular Proteomics : MCP|February 15, 2015
Mass spectrometric quantification of histone post-translational modifications by a hybrid chemical labeling methodTobias M Maile, Anita Izrael-Tomasevic, Tommy Cheung, et al.
The Journal of Biological Chemistry|October 8, 2009
The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrateYan Li, Patrick Trojer, Chong-Feng Xu, et al.
Pageof 6